000 | 01450 a2200421 4500 | ||
---|---|---|---|
005 | 20250517124350.0 | ||
264 | 0 | _c20171121 | |
008 | 201711s 0 0 eng d | ||
022 | _a2044-6055 | ||
024 | 7 |
_a10.1136/bmjopen-2016-012550 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKhaliq, Waseem | |
245 | 0 | 0 |
_aPrevalence of chemopreventive agent use among hospitalised women at high risk for breast cancer: a cross-sectional study. _h[electronic resource] |
260 |
_bBMJ open _c11 2016 |
||
300 |
_ae012550 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAcademic Medical Centers |
650 | 0 | 4 | _aAge Distribution |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnticarcinogenic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aChemoprevention _xstatistics & numerical data |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMaryland |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Reduction Behavior |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSurveys and Questionnaires |
700 | 1 | _aJelovac, Danijela | |
700 | 1 | _aWright, Scott M | |
773 | 0 |
_tBMJ open _gvol. 6 _gno. 11 _gp. e012550 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmjopen-2016-012550 _zAvailable from publisher's website |
999 |
_c26609559 _d26609559 |